These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1569343)

  • 1. Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons.
    Bollinger RC; Kline RL; Francis HL; Moss MW; Bartlett JG; Quinn TC
    J Infect Dis; 1992 May; 165(5):913-6. PubMed ID: 1569343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved method for monitoring efficacy of anti-retroviral therapy in HIV-infected individuals: a highly sensitive HIV p24 antigen assay.
    Reddy MM; Winger EE; Hargrove D; McHugh T; McKinley GF; Grieco MH
    J Clin Lab Anal; 1992; 6(3):125-9. PubMed ID: 1506978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
    Goldstein G; Conant MA; Beall G; Grossman HA; Galpin JE; Blick G; Calabrese LH; Hirsch RL; Fisher A; Stampone P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):279-88. PubMed ID: 7859140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection.
    Passaes C; Delagreverie HM; Avettand-Fenoel V; David A; Monceaux V; Essat A; Müller-Trutwin M; Duffy D; De Castro N; Wittkop L; Rouzioux C; Molina JM; Meyer L; Delaugerre C; Sáez-Cirión A
    J Virol; 2021 Jun; 95(14):e0001621. PubMed ID: 33952636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid dissociation of immune complexes improves diagnostic utility of p24 antigen detection in perinatally acquired human immunodeficiency virus infection.
    Quinn TC; Kline R; Moss MW; Livingston RA; Hutton N
    J Infect Dis; 1993 May; 167(5):1193-6. PubMed ID: 8486954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories.
    DeGruttola V; Beckett LA; Coombs RW; Arduino JM; Balfour HH; Rasheed S; Hollinger FB; Fischl MA; Volberding P
    J Infect Dis; 1994 Apr; 169(4):713-21. PubMed ID: 8133085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological correlates of immune-complex-dissociated HIV-1 p24 antigen in HIV-1-infected children.
    Duiculescu DC; Geffin RB; Scott GB; Scott WA
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):807-15. PubMed ID: 7912730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigen.
    Morand-Joubert L; Costagliola D; Bludau H; Petit JC; Lefrère JJ
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):676-80. PubMed ID: 8207645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of immune-complex-dissociated p24 antigen detection in perinatally acquired HIV-1 infection in Rwanda.
    Bulterys M; Farzadegan H; Chao A; Dushimimana A; Voltz A; Nawrocki P; Kurawige JB; Saah AJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):186-91. PubMed ID: 7552484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidification modified p24 antigen capture assay in HIV seropositives.
    Ascher DP; Roberts C; Fowler A
    J Acquir Immune Defic Syndr (1988); 1992; 5(11):1080-3. PubMed ID: 1403637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantification of the levels of p24 antigen and antibodies in human immunodeficiency virus infection].
    García F; Quirós E; Bernal MC; Alados JC; González MI; Maroto MC
    Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):75-8. PubMed ID: 1643142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
    J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium.
    Miles SA; Balden E; Magpantay L; Wei L; Leiblein A; Hofheinz D; Toedter G; Stiehm ER; Bryson Y
    N Engl J Med; 1993 Feb; 328(5):297-302. PubMed ID: 8419814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study Group.
    Brown AE; Vahey MT; Zhou SY; Chung RC; Ruiz NM; Hofheinz D; Lane JR; Mayers DL
    J Infect Dis; 1995 Oct; 172(4):1091-5. PubMed ID: 7561186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants.
    Lewis DE; Adu-Oppong A; Hollinger FB; Rosenblatt HM; Hanson IC; Reuben JM; Kline MW; Kozinetz CA; Shearer WT
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):87-90. PubMed ID: 7719918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection.
    Nadal D; Böni J; Kind C; Varnier OE; Steiner F; Tomasik Z; Schüpbach J
    J Infect Dis; 1999 Oct; 180(4):1089-95. PubMed ID: 10479135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.